Furosemide
Average across 11 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Lifestar Pharma LLC | unknown | 7 | SUPPLYING |
| Baxter Healthcare Corporation | brand | 6 | SUPPLYING |
| Medical Purchasing Solutions, LLC | repackager | 5 | SUPPLYING |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | generic | 5 | SUPPLYING |
| Northstar Rx LLC | relabeler | 3 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | generic | 3 | SUPPLYING |
| Devatis Inc. | unknown | 3 | SUPPLYING |
| HF Acquisition Co LLC, DBA HealthFirst | repackager | 2 | SUPPLYING |
| ProPharma Distribution | relabeler | 2 | SUPPLYING |
| Henry Schein, Inc. | relabeler | 2 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 1 | SUPPLYING |
| Cardinal Health 107, LLC | repackager | 1 | SUPPLYING |
| Civica, Inc | unknown | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Furosemide Injection — reported in shortage by Baxter Healthcare. Therapeutic category: Cardiovascular.
Furosemide Injection — reported in shortage by Avet Pharmaceuticals, Inc.. Therapeutic category: Cardiovascular.
